Published in Int J Radiat Oncol Biol Phys on February 01, 2015
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy. J Breast Cancer (2016) 0.75
Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06). Clin Breast Cancer (2015) 0.87
The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center. Radiat Oncol J (2015) 0.86
Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon. Radiat Oncol J (2014) 0.85
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer. Radiat Oncol J (2014) 0.81
Rare Case of Anal Canal Signet Ring Cell Carcinoma Associated with Perianal and Vulvar Pagetoid Spread. J Pathol Transl Med (2015) 0.81
Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07). Clin Breast Cancer (2014) 0.81
Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. Cancer Res Treat (2014) 0.80
The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res Treat (2014) 0.80
Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer. Cancer Res Treat (2015) 0.80
Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J (2013) 0.79
Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience. Radiat Oncol J (2016) 0.79
Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma : Results of Korean Radiation Oncology Group 1207 study. Strahlenther Onkol (2016) 0.78
Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer. Radiat Oncol J (2015) 0.78
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Cancer Genet (2014) 0.78
Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases. Radiat Oncol J (2014) 0.78
Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy. Radiat Oncol J (2015) 0.78
Incorporating Risk Factors to Identify the Indication of Post-Mastectomy Radiotherapy in N1 Breast Cancer Treated With Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23). Cancer Res Treat (2016) 0.78
Aggressive clinical course of extramammary Paget disease after radiotherapy. Radiat Oncol J (2014) 0.78
Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07). Cancer Res Treat (2016) 0.78
Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma. Oncotarget (2016) 0.77
Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer. Radiat Oncol J (2015) 0.77
Asian Society of Gynecologic Oncology International Workshop 2014. J Gynecol Oncol (2015) 0.77
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Liver Int (2016) 0.77
Exome sequencing in a breast cancer family without BRCA mutation. Radiat Oncol J (2015) 0.77
Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer. Radiat Oncol J (2015) 0.77
High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma. Oncotarget (2016) 0.77
Current status of brachytherapy in Korea: a national survey of radiation oncologists. J Gynecol Oncol (2016) 0.76
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget (2016) 0.76
Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients? Cancer Res Treat (2015) 0.75
The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups. PLoS One (2016) 0.75
Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study. Radiat Oncol J (2015) 0.75
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer. J Breast Cancer (2015) 0.75
Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma. Radiat Oncol J (2016) 0.75
Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma. Cancer Res Treat (2015) 0.75
Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08). J Gynecol Oncol (2016) 0.75
Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy. Sci Rep (2017) 0.75
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. Cancer Res Treat (2016) 0.75
Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer. Radiat Oncol J (2016) 0.75
Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells. Radiat Oncol J (2016) 0.75
Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer. Radiat Oncol J (2016) 0.75
Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors. PLoS One (2016) 0.75
Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09). J Gynecol Oncol (2016) 0.75
Evaluation of Dose Distribution in Intensity Modulated Radiosurgery for Lung Cancer under Condition of Respiratory Motion. PLoS One (2016) 0.75
Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study. J Breast Cancer (2016) 0.75
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast. J Breast Cancer (2015) 0.75
A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. J Neurooncol (2015) 0.75
Current status and trend of the publication to the SCI and SCIE journals in the field of radiation oncology in Korea for 30 years. Radiat Oncol J (2012) 0.75
Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? Liver Int (2017) 0.75
Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study. Radiat Oncol J (2017) 0.75
Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery. J Gastroenterol Hepatol (2016) 0.75
The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Res Treat (2017) 0.75
Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer. Radiat Oncol J (2017) 0.75
Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J (2017) 0.75
Dosimetric evaluation of MobiusFX in the RapidArc delivery quality assurance comparing with 3DVH. PLoS One (2017) 0.75
Post-mastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418). Cancer Res Treat (2016) 0.75
Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective. Clin Breast Cancer (2017) 0.75
Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline plus Taxane-based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study. Cancer Res Treat (2017) 0.75
Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea. J Breast Cancer (2017) 0.75
Interobserver variation in target volume for salvage radiotherapy in recurrent prostate cancer patients after radical prostatectomy using CT versus combined CT and MRI: a multicenter study (KROG 13-11). Radiat Oncol J (2017) 0.75